Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin versus doxycycline and placebo in rosacea
2006-002410-35Phase 2Completed
- Sponsor
- Almirall
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of isotretinoin and doxycycline in rosacea, papulopustular rosacea and Phymatous Rosacea (5 arms), sponsored by Almirall. Primary endpoint: Primary efficacy endpoint. Started Feb 2007; status: completed.
02
Drugs
isotretinoindoxycycline
03
Conditions
rosaceapapulopustular rosaceaPhymatous Rosacea
Beyond the preview
Go deeper on 2006-002410-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002410-35.